Here's your chance to get your Brainstorm questions answered:
NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that its senior management will hold a conference call on Wednesday, July 25, 2012 at 8:00 a.m. EDT in Hebrew and at 8:45 a.m. EDT in English.
Dr. Adrian Harel, Chief Executive Officer, Mr. Chaim Lebovits, President, Ms. Liat Sossover, Chief Financial Officer, and Prof. Daniel Offen, PhD, Chief Scientific Advisor, will discuss the results of the Company’s recent interim safety report and other developments.
Callers may participate in the conference call by dialing:
USA: 1-888-407-2553
Israel: 1-800-227-297 (Hebrew at 08:00 a.m. EDT), or 1-800-270-345 (English at 08:45 a.m. EDT).
International: +972-3-918-0664
Callers are invited to ask relevant questions during the conference call. Questions may also be pre-submitted to
info@brainstorm-cell.com prior to 7:00 a.m. EDT on Wednesday, July 25, 2012.
A recording of the conference will be available for download Monday, July 30, 2012 from the company’s website at the following link:
http://bit.ly/OVVV6F.Louis
PS. I'm surprised that Brainstorm's shares went down to $0.27 a share after the recent announcement that the safety trial was successful. I guess that everyone already knew what they were going to say.